Financial results - ADDENDA PHARMACEUTICALS S.R.L.

Financial Summary - Addenda Pharmaceuticals S.r.l.
Unique identification code: 40388581
Registration number: J2019000178406
Nace: 4646
Sales - Ron
68.199.248
Net Profit - Ron
1.527.315
Employees
7
Open Account
Company Addenda Pharmaceuticals S.r.l. with Fiscal Code 40388581 recorded a turnover of 2024 of 68.199.248, with a net profit of 1.527.315 and having an average number of employees of 7. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Addenda Pharmaceuticals S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 641.596 3.307.612 14.569.228 45.145.560 56.321.693 68.199.248
Total Income - EUR - - - - 644.717 3.316.135 14.615.797 45.293.749 56.761.503 69.066.386
Total Expenses - EUR - - - - 530.334 3.203.352 14.297.218 44.198.559 54.922.875 66.848.809
Gross Profit/Loss - EUR - - - - 114.383 112.783 318.579 1.095.190 1.838.628 2.217.576
Net Profit/Loss - EUR - - - - 94.818 103.967 271.201 942.834 1.579.487 1.527.315
Employees - - - - 4 5 5 5 7 7
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 21.8%, from 56.321.693 euro in the year 2023, to 68.199.248 euro in 2024. The Net Profit decreased by -43.345 euro, from 1.579.487 euro in 2023, to 1.527.315 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Addenda Pharmaceuticals S.r.l.

Rating financiar

Financial Rating -
ADDENDA PHARMACEUTICALS S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Addenda Pharmaceuticals S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Addenda Pharmaceuticals S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Addenda Pharmaceuticals S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Addenda Pharmaceuticals S.r.l. - CUI 40388581

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 4.173 4.046 4.906 5.449 5.160 15.727
Current Assets - - - - 887.472 2.087.276 18.221.879 29.597.811 35.196.187 59.716.252
Inventories - - - - 221.815 546.811 5.644.206 6.150.837 5.474.379 8.726.798
Receivables - - - - 665.658 1.540.465 12.577.673 23.446.974 29.721.809 50.687.379
Cash - - - - 0 0 0 0 0 302.074
Shareholders Funds - - - - 147.501 248.672 514.358 1.458.788 3.033.852 4.214.472
Social Capital - - - - 52.683 51.684 50.538 50.695 50.541 70.848
Debts - - - - 744.739 1.853.489 17.731.525 28.163.690 32.174.688 55.510.274
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 59.716.252 euro in 2024 which includes Inventories of 8.726.798 euro, Receivables of 50.687.379 euro and cash availability of 302.074 euro.
The company's Equity was valued at 4.214.472 euro, while total Liabilities amounted to 55.510.274 euro. Equity increased by 1.197.575 euro, from 3.033.852 euro in 2023, to 4.214.472 in 2024.

Risk Reports Prices

Reviews - Addenda Pharmaceuticals S.r.l.

Comments - Addenda Pharmaceuticals S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.